CN Patent

CN101068533B — 含有抗成核剂的药物组合物

Assigned to Merck Sharp and Dohme LLC · Expires 2011-04-27 · 15y expired

What this patent protects

本发明涉及一种适于以固体剂型口服给药的药物组合物。该组合物中含有有效量的盐形式的药物化合物，其中该盐的特征为药物化合物在超过或低于其固有pH的GI-相关的pH转化为较少可溶的形式，和抗成核剂。

USPTO Abstract

本发明涉及一种适于以固体剂型口服给药的药物组合物。该组合物中含有有效量的盐形式的药物化合物，其中该盐的特征为药物化合物在超过或低于其固有pH的GI-相关的pH转化为较少可溶的形式，和抗成核剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN101068533B
Jurisdiction
CN
Classification
—
Expires
2011-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.